Osteoporosis Most Recent
Targeting RANK Ligand Increases Bone Mineral Density||in Postmenopausal Women: Results from Phase 3 Trials
Dr. Alexandra Papaioannou reviewed the results of Phase 3 trials of denosumab, which she described “an exciting new compound” under investigation.
Dr. Earl Bogoch’s key message concerned the importance of identifying and treating osteoporosis after a fragility fracture, in order to prevent future fractures, most importantly of the hip.
Vertebral compression fractures (VCF) are the hallmark of osteoporosis, yet two-thirds of all VCF remain undiagnosed and untreated.
MD, FRCPC, FACP, AGSF
Successful management of osteoporosis includes nonpharmacologic and pharmacologic strategies, aimed at fracture prevention.
POWER in Osteoporosis: Descriptive Review of a Multidisciplinary Community-Based Prevention and Management ProgramMD, MSc, FRCPC, FACP, FRCPEdin